<DOC>
	<DOCNO>NCT00602420</DOCNO>
	<brief_summary>RATIONALE : Naproxen may help prevent lessen bone pain cause pegfilgrastim . It yet know whether naproxen effective placebo prevent bone pain cause pegfilgrastim patient non-hematologic cancer undergo chemotherapy . PURPOSE : This randomized phase III trial study naproxen see well work compare placebo prevent bone pain cause pegfilgrastim patient non-hematologic cancer undergo chemotherapy .</brief_summary>
	<brief_title>Prevention Pegfilgrastim-Induced Bone Pain ( PIBP )</brief_title>
	<detailed_description>OBJECTIVES : Primary - To compare efficacy daily administration naproxen vs placebo prevent reduce severity duration pegfilgrastim-induced bone pain ( PIBP ) patient non-hematologic malignancy undergo chemotherapy . Secondary - To identify potential risk factor development PIBP . - To identify potential clinical predictor response failure respond naproxen prevent PIBP . - To assess toxicity naproxen administer preventive setting . OUTLINE : This multicenter study . Patients stratify Clinical Community Oncology Program ( CCOP ) site . Patients randomize 1 treatment arm v placebo . - Arm I : Patients receive oral naproxen twice daily begin day pegfilgrastim administer ( day 2 , 3 , 4 ) continue 5-8 day . - Arm II : Patients receive match placebo twice daily begin day pegfilgrastim administer ( day 2 , 3 , 4 ) continue 5-8 day .</detailed_description>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Diagnosis nonhematologic ( nonmyeloid ) malignancy Scheduled receive chemotherapy ; chemotherapy may give adjuvant , neoadjuvant , curative , palliative intent Scheduled receive first dose pegfilgrastim ( Neulasta® ) ameliorate chemotherapyinduced neutropenia Creatinine ≤ 1.5 time upper limit normal Able understand English More 6 month since prior surgery heart Pregnant nursing Clinical evidence active gastrointestinal bleeding , prior gastrointestinal bleeding , gastric duodenal ulcer Allergy naproxen Prior development triad asthma , rhinitis , nasal polyp take acetylsalicylic acid ( aspirin ) NSAIDs Concurrent nonsteroidal antiinflammatory drug ( NSAIDs ) , aspirin , ibuprofen , product contain naproxen ( e.g. , Naprosyn , ECNaprosyn , Anaprox , AnaproxDS , Naprosyn suspension , Aleve ) , regular basis Concurrent steroid regular basis Concurrent prescription nonprescription medication preexist chronic pain ; concurrent cardioprotective dos ( ≤ 325 mg/day ) aspirin allow Concurrent therapeutic dos warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>pain</keyword>
	<keyword>musculoskeletal complication</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>